Research Article

Open Access
Short-duration splice promoting compound enables a tunable mouse model of spinal muscular atrophy
Anne Rietz, Kevin J Hodgetts, Hrvoje Lusic, Kevin M Quist, View ORCID ProfileErkan Y Osman, View ORCID ProfileChristian L Lorson, View ORCID ProfileElliot J Androphy Correspondence email
Anne Rietz
1Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA
Kevin J Hodgetts
2Laboratory for Drug Discovery in Neurodegeneration, Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, USA
Hrvoje Lusic
2Laboratory for Drug Discovery in Neurodegeneration, Brigham and Women’s Hospital, Harvard Medical School, Cambridge, MA, USA
Kevin M Quist
1Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA
Erkan Y Osman
3Department of Veterinary Pathobiology, Bond Life Sciences Center, College of Veterinary Medicine, University of Missouri, Columbia, MO, USA
Christian L Lorson
3Department of Veterinary Pathobiology, Bond Life Sciences Center, College of Veterinary Medicine, University of Missouri, Columbia, MO, USA
Elliot J Androphy
1Department of Dermatology, Indiana University School of Medicine, Indianapolis, IN, USA
Published 24 November 2020. DOI: 10.26508/lsa.202000889
A pharmacologically tunable SMA mouse model
Anne Rietz, Kevin J Hodgetts, Hrvoje Lusic, Kevin M Quist, Erkan Y Osman, Christian L Lorson, Elliot J Androphy
Life Science Alliance Nov 2020, 4 (1) e202000889; DOI: 10.26508/lsa.202000889
In this Issue
Volume 4, No. 1
January 2021
Advertisement
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.